Drobyski WR - Search Results

1

Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.

Yuan CY, Zhou V, Sauber G, Stollenwerk T, Komorowski R, López A, Tolón RM, Romero J, Hillard CJ, Drobyski WR. Yuan CY, et al. Among authors: drobyski wr. Blood. 2021 Mar 4;137(9):1241-1255. doi: 10.1182/blood.2020004871. Blood. 2021. PMID: 33027805 Free PMC article.

2

Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism.

Drobyski W, Thibodeau S, Truitt RL, Baxter-Lowe LA, Gorski J, Jenkins R, Gottschall J, Ash RC. Drobyski W, et al. Blood. 1989 Nov 1;74(6):2285-94. Blood. 1989. PMID: 2572285 Free article.

3

Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation.

Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW. Drobyski WR, et al. Blood. 1994 Oct 1;84(7):2363-73. Blood. 1994. PMID: 7522627 Free article.

4

Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR. Hessner MJ, et al. Among authors: drobyski wr. Blood. 1995 Nov 15;86(10):3987-96. Blood. 1995. PMID: 7579370 Free article.

5

Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.

Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F, et al. Drobyski WR, et al. Blood. 1994 Apr 1;83(7):1980-7. Blood. 1994. PMID: 8142664 Free article.

6

Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose.

Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM, et al. Drobyski WR, et al. Blood. 1993 Oct 15;82(8):2310-8. Blood. 1993. PMID: 8400284 Free article.

7

Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.

Johnson BD, Drobyski WR, Truitt RL. Johnson BD, et al. Among authors: drobyski wr. Bone Marrow Transplant. 1993 Apr;11(4):329-36. Bone Marrow Transplant. 1993. PMID: 8485480

8

Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.

Drobyski WR, Majewski D. Drobyski WR, et al. Blood. 1996 Jun 15;87(12):5355-69. Blood. 1996. PMID: 8652851 Free article.

9

Modulation of in vitro and in vivo T-cell responses by transferrin-gallium and gallium nitrate.

Drobyski WR, Ul-Haq R, Majewski D, Chitambar CR. Drobyski WR, et al. Blood. 1996 Oct 15;88(8):3056-64. Blood. 1996. PMID: 8874204 Free article.

10

Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice.

Drobyski WR, Majewski D. Drobyski WR, et al. Blood. 1997 Feb 1;89(3):1100-9. Blood. 1997. PMID: 9028343 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters